Shopping Cart
- Remove All
- Your shopping cart is currently empty
Neuraminidase-IN-18 (compound N5), a novel polyheterocyclic neuraminidase (NA) inhibitor, demonstrates significant inhibitory activity against H5N1 NA, with an IC 50 of 0.14 μM against the wild-type H5N1 NA and 0.27 μM against the H5N1-H274Y mutant NA. This compound effectively binds to NAs, inhibiting influenza virus replication at the cellular level [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Neuraminidase-IN-18 (compound N5), a novel polyheterocyclic neuraminidase (NA) inhibitor, demonstrates significant inhibitory activity against H5N1 NA, with an IC 50 of 0.14 μM against the wild-type H5N1 NA and 0.27 μM against the H5N1-H274Y mutant NA. This compound effectively binds to NAs, inhibiting influenza virus replication at the cellular level [1]. |
In vitro | Neuraminidase-IN-18 (compound N5) demonstrates in vitro antiviral activity against H5N1, with an EC50 value of 3.70 μM, as shown by the CCK-8 method [1]. The aromatic fused ring and 1,3,4-oxadiazole ring in Neuraminidase-IN-18 are well-integrated into the active site, facilitating strong hydrogen bonding interactions with three positively charged key arginine residues (Arg118, Arg292, and Arg371) [1]. |
Molecular Weight | 423.46 |
Formula | C22H18FN3O3S |
Cas No. | 2935407-32-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.